UK Prime Minister Boris Johnson has cautiously welcomed the promising results from the Pfizer/BioNTech vaccine and warned people not to rely on this news as a solution as it is still “very, very early days”.
Addressing a briefing from 10 Downing Street here on Monday, Johnson urged the British public not to “slacken” their resolve as it is still “very, very early days”, even as he confirmed that the UK had pre-ordered 40 million doses of the Pfizer vaccine – enough for about a third of the UK population, taking into account that two doses each are required.
“The Pfizer/BioNTech Vaccine has been tested on over 40,000 volunteers and interim results suggest it is proving 90 per cent effective at protecting people against the virus. But we haven't yet seen the full safety data, and these findings also need to be peer-reviewed,” said Johnson.